COMPARISON BETWEEN BASKA MASK AND I-Gel INSERTION IN MINOR SURGERIESUNDER GENERAL ANAESTHESIA IN PATIENT AGED 18-50 Y:-A RANDOMIZEDINTERVENTIONAL STUDY

Abstract

Objective: The supraglottic airway (SAD) is considered a viable alternative to endotracheal intubation, particularly in cases where SAD is not contraindicated. SAD plays a crucial role in difficult airway algorithms, offering unobstructed oxygenation and ventilation, as well as providing hemodynamic stability with minimal laryngopharyngeal morbidity. The LMA-classic, introduced by Archie Brain in 1983, was the first second-generation SAD used in clinical practice. Over time, numerous advancements have led to the development of improved second-generation SADs. Methods: This study aims to compare the efficacy and advantages of different supraglottic airway devices. Two types of second-generation SADs were evaluated:I-gel (Intersurgical, Wokingham, UK) and a novel device called Baska Mask, which belongs to the third generation of SADs. The evaluation criteria included ease of insertion, oropharyngeal sealing pressure, ability to drain gastric fluid, prevention of malposition, sealing pressure during controlled ventilation and spontaneous breathing, and reduction of respiratory complications. Results: The second-generation SADs, including the I-gel, are easy to insert and offer high oropharyngeal sealing pressure. They have a gastric channel to drain gastric fluid, reducing aspiration risk. The I-gel, a new latex-free SAD with a noninflatable cuff made of medical-grade thermoplastic elastomer, provides a superior seal, resulting in lower respiratory complications compared to earlier SADs. It ensures effective sealing during controlled ventilation and spontaneous breathing. The third-generation Baska Mask combines the advantages of second-generation LMAs and provides higher seal pressure during IPPV by apposing to the glottis, distinguishing it from non-inflatable cuff devices like the I-gel. Conclusion: Supraglottic airway devices, particularly second-generation SADs like I-gel, offer effective airway management alternatives to endotracheal intubation. These devices provide ease of insertion, high oropharyngeal sealing pressure, and the ability to drain gastric fluid, reducing the risk of complications. The third-generation device, Baska Mask, exhibits enhanced seal pressure during IPPV, making it a promising advancement in airway management.